DexCom, Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $29.7M |
| Cost of Revenue | $26.0M |
| Gross Profit | $3.7M |
| Gross Margin | 12.3% |
| Operating Expenses | |
| Research & Development | $14.3M |
| SG&A Expense | $35.2M |
| Operating Income | $-45.8M |
| Operating Margin | -154.4% |
| Interest Expense | $8.0M |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-53.5M |
| Net Margin | -180.3% |
| EPS (Basic) | $-0.24 |
| EPS (Diluted) | $-0.24 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |